Background: Previous studies have found an increased risk for invasive cutaneous melanoma (CM) among those with a history of keratinocyte carcinoma (KC).
M elanoma is the most lethal among common forms of skin cancer. As the fifth most common cancer among males and sixth among females (excluding nonmelanoma skin cancers), the estimated number of new melanoma cases in the United States in 2017 was 87,110 and the estimated number of deaths of melanoma was 9730. 1 The prognosis of melanoma is highly heterogeneous. 2 Patients whose melanoma is diagnosed in stage I have a much favorable prognosis, with a higher than 90% 5-year survival rate whereas the 5-year survival rate for patients with stage IV (distant) disease is around 15%. 3 There has been a discrepancy between melanoma incidence and mortality over the past 2 decades; melanoma incidence has dramatically risen, but melanoma mortality has recently stabilized. 4, 5 Keratinocyte carcinoma (KC), including cutaneous basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), are the most commonly diagnosed malignancies in the United States, with 3.5 million cases each year. 6 It has been suggested that KC and other cancers may share common carcinogenic exposures or molecular mechanisms in their etiology, such as DNA repair deficiency and immune suppression, implying that a history of KC may indicate an increased risk for subsequent cancer development. We previously reported an increased risk for cancer associated with history of KC, including melanoma in men and breast cancer, lung cancer, and melanoma in women. 7 In addition, Wu et al recently reported that a personal history of KC was associated with increased risk for melanoma (hazard ratio [HR], 2.22; 95% confidence interval [CI], 1.73-2.85), 8 which is consistent with previous reports from registry-based, case-control, and prospective cohort studies. [9] [10] [11] [12] Although the association of a personal history of KC with melanoma risk has been consistently reported, its association with melanoma mortality remains undetermined. A study 2 decades ago reported that increased mortality due to overall cancer and melanoma after the diagnosis of KC may be due to shared exposures or susceptibilities. 13 However, this association was not further replicated in later years.
14 Does a history of KC increase the risk for melanoma death, and do patients with melanoma with a history of KC have poorer prognoses? To answer these questions, we conducted a prospective cohort study using data from the Health Professionals Follow-up Study (HPFS).
METHODS

Study population
The HPFS was started in 1986 and enrolled 51,529 American male health care professionals age 40 to 75 years. Participants receive a biennial survey regarding their personal health information and lifestyle. Response rates are higher than 90%. Our study period includes data collected from the cohort in surveys from 1986 to 2012. Only white patients (both Hispanic and non-Hispanic whites) were included in our analysis, given the different risks for development of melanoma among different races. 15 Our study was approved by the Human Research Committee of the Harvard T.H. Chan School of Public Health (Boston, MA).
Assessment of exposure
In the HPFS, participants were asked about having received a diagnosis of BCC and SCC. Medical and pathological reports were obtained from participants who reported SCC to confirm the diagnosis. Medical records were not obtained for BCC cases because of a large number of cases in our cohort and because previous validation studies reported a more than 90% accuracy of self-reported BCC among subsets of cohort participants. 16 
Assessment of melanoma and death
Similar to assessment of exposure as already detailed, participants in both cohorts self-reported a diagnosis of melanoma. Afterward, permission was sought to access their medical records so that pathologic reports could be reviewed. We focused only on the mortality of confirmed invasive cases, and excluded those participants with lentigo maligna melanoma and melanoma in situ from this analysis because of their favorable prognosis. Self-reported cases that could not be confirmed were excluded. Information collected aside from melanoma diagnosis included major histopathologic factors, such as Breslow depth and Clark level. All information was updated up to 2012.
Death events were reviewed in 1 of 3 ways. Deaths were reported by next of kin or by the US Postal Service. Additionally, a search was made in the National Death Index for participants who did not respond to their surveys. Death certificates and when necessary, medical records, were used to determine the date of death. More than 98% of deaths in these 2 cohorts were confirmed by 1 of these methods. 17 Furthermore, cause of death was determined by
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blinded physician reviewers who reviewed death certificates. This was supplemented with family or health care provider interviews, as well as with medical records. The primary cancer was recorded as cause of death in cases of metastatic disease causing death.
Assessment of covariates
Covariate information was collected by selfreported questions on the biennial surveys. This included information on smoking, alcohol intake, body mass index, and physical activity. Questions about certain factors were asked at certain time points in the cohort. These included the following factors: number of blistering sunburns and tendency to burn as a child or adolescent, natural hair color, and family history of melanoma in first-degree relatives. Additionally, ultraviolet (UV) flux was calculated for each participant on the basis of his state of residence and by using a previously described method. 18 
Statistical analysis
We calculated person-years of follow-up from baseline to death or end of follow-up period, whichever came first. The year 1986 was set as the study baseline, and association of a history of KC with subsequent diagnosis of invasive cutaneous melanoma (CM) and melanoma death were examined until 2012 for the cohort. Melanoma deaths were considered the major end point, whereas deaths from other causes were censored. By using a Cox proportional hazards model stratified by age and follow-up cycles, we calculated HRs for melanoma death, comparing participants with and without a history of KC. The analyses were adjusted for the predetermined covariates (body mass index, smoking, alcohol intake, physical activity, childhood reaction to sun, number of sunburns, family history for melanoma, hair color, UV flux, and frequency of physical examination). Missing data for any covariate required creation of an indicator. In a secondary analysis, we looked at history of KC and its effect on incident cases of lethal melanoma and nonlethal melanoma. In this analysis, follow-up time was determined by the basis of date of melanoma diagnosis, death from any cause, or end of followup time, whichever came first. Similarly, we used a Cox proportional hazards model with adjustment for the same covariates.
Moreover, we analyzed the rate of death from melanoma among invasive melanoma cases to examine whether a history of KC is associated with a worse prognosis. In this analysis, we included participants from time of diagnosis of invasive melanoma and followed them until either the predetermined end time or death from any cause, whichever came first. Any death from all causes other than melanoma death was censored. As already described, HRs were calculated by using a Cox proportional hazards model with time in months since diagnosis as the time variable, adjusting for the same covariates. All analyses were carried out using SAS software (version 9.3, SAS Institute Inc, Cary, NC). All P values were 2 tailed with the significance level set at P less than .05.
RESULTS
A total of 579 of participants with invasive CM had no personal history of KC in the cohort, versus 329 who did carry a prior diagnosis of KC over 0.7 million years of follow-up. Baseline characteristics for the 2 groups are mostly similar (as shown in Table I ), except that the mean age at diagnosis for participants with invasive CM with a history of KC was older than that of participants without a history of KC: 72.9 years versus 66.5 years.
We examined the risk for development of either a lethal or nonlethal melanoma depending on history of KC. The age-adjusted HR for development of a lethal melanoma for those with a history of KC was 1.63 (95% CI, 1.01-2.61) when compared with those who had no such history. In multivariate analysis, this HR was 1.97 (95% CI, 1.21-3.20). For the risk of nonlethal melanoma, the HRs for age-adjusted and multivariate-adjusted modeling were 1.70 (95% CI, 1.44-2.01) and 1.61 (95% CI, 1.36-1.90) (Table II) .
When the HR of melanoma mortality was evaluated on the basis of a personal history of KC, the ageadjusted HR was 1.26 (95% CI, 0.79-2.00) in the HPFS. When covariates other than age were included in the model, the multivariate-adjusted HR was 1.53 (95% CI, 0.95-2.46) (Table III) . In addition, no significant association was found between a history of KC and melanoma thickness or invasiveness. We calculated the odds ratios (ORs) (95% CIs) for the association between personal history of KC and Breslow thickness of melanoma of 0.8 mm or Furthermore, in the melanoma caseeonly analysis, we found that a personal history of KC conferred an HR of 0.59 (95% CI, 0.37-0.94) in the age-adjusted model. Multivariate modeling revealed an HR of 0.60 (95% CI, 0.37-0.99), and in the more CI, Confidence interval; HR, hazard ratio; KC, keratinocyte melanoma. *Multivariate-adjusted analyses were performed with adjustment for age, smoking (never-smokers, past smokers, or current smokers), physical activity (in quintiles, metabolic equivalent h/wk), body mass index (\25, 25-29.9, or $30 kg/m 2 ), alcohol intake (0, 0-4.9, 5-9.9, or $10 g/d), childhood reaction to sun (tan without burn, burn, or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan), number of sunburns (0, 1-2, 3-5, or $6), hair color (red, blonde, light brown, or dark brown/black), family history of melanoma (yes or no), cumulative ultraviolet flux (in quintiles), and physical examination frequency. An indicator variable was created for the missing value of each covariate. All values shown were for the information at melanoma diagnosis or the questionnaire cycle closest to the melanoma diagnosis year except where otherwise noted. All variables other than age at diagnosis were adjusted for age at diagnosis. KC, Keratinocyte melanoma; RB, Robertson-Berger; SD, standard deviation; UV, ultraviolet.
complex multivariate model, which additionally controlled for Breslow thickness and Clark level, the HR was 0.60 (95% CI, 0.35-0.94) (Table IV) .
DISCUSSION
It has been reported that a personal history of KC is associated with an increased risk for invasive melanoma. In this prospective cohort study, we found no significantly increased mortality from melanoma among patients with a history of KC. Interestingly, in the melanoma caseeonly analysis, melanoma cases with such a history had significantly better survival than cases without a history of KC, suggesting a protective effect of a history of KC on melanoma death.
This could be explained logically by the idea that once a patient has a KC, they are more likely to undergo serial skin examinations with a dermatologist, 19 making the diagnosis of CM not only more likely but also more likely to be made earlier. Patients with a history of KC visit their dermatologists more often, thus having a better chance of having CMs diagnosed before the tumors start to metastasize. 20 This, combined with the previously described data showing an increase in melanoma diagnosis after a history of KC, suggests a detection bias leading to higher CM diagnosis rates. However, we did not observe that patients with a history of KC had thinner or less invasive melanomas.
It has been proposed that a history of KC is a marker for previous UV exposure, 21 which would explain both the increased incidence and diagnosis of lethal and nonlethal melanoma. 22 However, a population-based study of survival after a melanoma diagnosis suggests that some factors associated with high levels of sun exposure, such as solar elastosis and, to a lesser extent, sunburns and intermittent sun exposure, are inversely associated with death from melanoma. 23 Our data were consistent with this finding. Sun exposure is necessary for synthesis of 25-hydroxy vitamin D 3 in the skin, which is then converted to 1,25-dihydroxyvitamin D, which has antiproliferative and proapoptotic properties. It would be plausible to speculate that the inverse relationship between sun exposure and survival of melanoma could be mediated by vitamin D.
Additionally, melanomas that develop in patients with prior KC likely occur because of similar pathways involving UV exposure. However, melanomas that occur in patients without a history of KC ), alcohol intake (0, 0-4.9, 5-9.9, or $10 g/d), childhood reaction to sun (tan without burn, burn, or painful burn/blisters), childhood tanning ability (practically none, little tan, average tan, or deep tan), number of sunburns (0, 1-2, 3-5, or $6), hair color (red, blonde, light brown, or dark brown/black), family history of melanoma (yes or no), cumulative ultraviolet flux (in quintiles), and physical examination frequency. An indicator variable was created for the missing value of each covariate.
or with lower levels of sun exposure are more likely due to nonmodifiable host factors, such as genetic predisposition and nevus count. [24] [25] [26] The latter group may have more aggressive melanomas leading to death in a shorter period of follow-up. In essence, a history of KC does increase the risk of CM and death from it. However, if people develop a CM without a history of KC, they are at higher risk for death, given the possibility of a more aggressive tumor.
Our study has both limitations and strengths. One limitation is that because the HPFS population consists solely of male health professionals, who may have sun exposure-related or other behaviors different from those of the general population, the results of this study may not be applicable to the whole population. For example, a participant in the HPFS study is less likely to be a current smoker compared with the general population 27 but more likely to be a moderate or heavy drinker. 28, 29 In addition, HPFS participants have higher levels of health awareness and are more likely to undergo screening and early detection. Furthermore, we have documented previously that the incidence of melanoma is higher in our cohort 30 than in the general population, 31 as high socioeconomic status and intermittent sun exposure patterns have been associated with an increased risk for melanoma. 32 For KC, the HPFS has an incidence similar to that in the general population. [33] [34] [35] Another limitation is that patients were studied from 1986 to 2012, and advances in therapy for metastatic melanoma have improved dramatically in the past few years. As such, it is reasonable to conjecture that if a study were to begin now, the rate of death due to melanoma might be lower, or at least we might see a longer time to death from melanoma after the date of diagnosis. However, one could also posit that with longer survival from advanced therapies come higher costs, indicating that prevention and early detection are still of the utmost importance for both mortality and health care spending. In addition, we did not have complete information on subtype of melanoma, which is an important factor for melanoma prognosis. Furthermore, recall bias regarding factors such as childhood reaction to sun, childhood tanning ability, and times of sunburns may exist during data collection. As for strengths, participants in the HPFS are all health care professionals. As such, their own likelihood of following up with physicians after an event such as KC is higher. Our calculations likely represent true estimates in ideal circumstances, which is helpful when quoting risks for patients.
In summary, we found no significantly increased mortality among people with a personal history of KC. However, among patients with invasive melanoma, those with a history of KC were found to have better survival than patients without a history of KC. Further studies are warranted to investigate the mechanism underlying this inverse association.
